Randomized Placebo-Controlled Phase 2 Study of Extended-Release Ketamine Tablets (R-107) for Treatment-Resistant Depression – the BEDROC Study

Allan Young

Randomized Placebo-Controlled Phase 2 Study of Extended-Release Ketamine Tablets (R-107) for Treatment-Resistant Depression – the BEDROC Study

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	A129207B
Journal	Nature Medicine
Publication status	Accepted/In press - 9 May 2024

Cite this

@article{4aa53939d01b408c97d54586a9519328,

title = "Randomized Placebo-Controlled Phase 2 Study of Extended-Release Ketamine Tablets (R-107) for Treatment-Resistant Depression – the BEDROC Study",

author = "Allan Young",

year = "2024",

month = may,

day = "9",

language = "English",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

}